Who is running cardiometabolic trials
Among studies registered with a start date since 1 July 2026, the most frequent lead sponsors in cardiovascular disease are:
- Assiut University — 32 studies
- Mayo Clinic — 11 studies
- Silvia Ulrich Somaini — 8 studies
- University of Texas Southwestern Medical Center — 7 studies
- Assistance Publique – Hôpitaux de Paris — 7 studies
- University of Alabama at Birmingham — 7 studies
University hospitals and academic centres lead the count, and the list is more international than people tend to assume — a reminder that the registry covers studies worldwide, not only those run in the United States.
Counting records is not counting scale
A sponsor running thirty small single-centre studies appears far more active than one running a single trial across forty countries. Frequency in the registry measures how often an organisation registers a study, which is a different question from how much research it is doing.
Counts taken from the ClinicalTrials.gov API on 7 October 2026, covering studies with a registered start date on or after 1 July 2026. Registry numbers move as records are added and updated, so treat them as a snapshot rather than a fixed figure.